Design, synthesis and molecular docking of novel N,N-dimethylbenzenesulfonamide derivatives as potential antiproliferative agents

References

• Available from http://www.who.int/gho/ncd/mortality_morbidity/cancer_text/en/index.html [last accessed 12 June 2013]
   Google Scholar
• Matsuo H, Wakasugi M, Takanaga H, et al. Possibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoprotein. Contr Rel 2001;77:77–86
   PubMed Web of Science ®Google Scholar
• Fahad-Ullah M. Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy. Asian Pac J Cancer Preven 2008;9:1–6
   PubMedGoogle Scholar
• (a) Marques SM, Enyedy EA, Supuran CT, et al. Pteridine--sulfonamide conjugates as dual inhibitors of carbonic anhydrases and dihydrofolate reductase with potential antitumor activity. Bioorg Med Chem 2010;18:5081–9. (b) Ghorab MM, Ragab FA, Heiba HI, et al. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety. Med Chem Res 2011; 20:388–400. (c) Ghorab MM, Ragab FA, Heiba HI, et al. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety. Eur J Med Chem 2010;45:3677–84. (d) Abbate F, Casini A, Owa T, et al. Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX. Bioorg Med Chem Lett 2004;14:217–23. (e) Stephens CE, Felder TM, Sowell JW, et al. Synthesis and antiviral/antitumor evaluation of 2-amino- and 2-carboxamido-3-arylsulfonylthiophenes and related compounds as a new class of diarylsulfones. Bioorg Med Chem 2001;9:1123–32
   Google Scholar
• (a) Moorthy NS, Cerqueira NS, Ramos MJ, Fernandes PA. QSAR analysis of 2-benzoxazolyl hydrazone derivatives for anticancer activity and its possible target prediction. Med Chem Res 2012;21:133–44. (b) Patila BR, Machakanura SS, Hunoora RS, et al. Synthesis and anti-cancer evaluation of cyclotriphosphazene hydrazone derivatives. Der Pharma Chemica 2011;3:377–88
   Google Scholar
• (a) Greenfeld DL, Benhar I. Risks and untoward toxicities of antibody-based immunoconjugates. Adv Drug Delivery Rev 2012;64:1782–99. (b) Bharadwaj AS, Appukuttan B, Wilmarth PA, et al. Role of the retinal vascular endothelial cell in ocular disease. Prog Retinal Eye Res 2013;32:102–80. (c) Renoir JM. Estradiol receptors in breast cancer cells: associated co-factors as targets for new therapeutic approaches. Steroids 2012;77:1249–61. (d) Lee EH, Oh SY, Sung MK. Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells. Food Chem Tox 2012;50:4136–43
   Google Scholar
• (a) Bassyouni FA, Tawfik HA, Soliman AM, Abdel Rehim M. Synthesis and anticancer activity of some new pyridine derivatives. Res Chem Intermed 2012;38:1291–310. (b) Amr AE, Mohamed AM, Mohamed SF, Abdel-Hafez NA, Hammam. Anticancer activities of some newly synthesized pyridine, pyrane, and pyrimidine derivatives. Bioorg Med Chem 2006;14:5481–8
   Google Scholar
• (a) Ahmed MM, Khan MA, Rainsford KD. Synthesis of thiophene and NO-curcuminoids for antiinflammatory and anti-cancer activities. Molecules 2013; 18:1483–501. (b) El-Gaby MSA, Ismail ZH, Abdel-Gawad SM, et al. Synthesis of thiazolidine and thiophene derivatives for evaluation as anticancer agents. Phosphorous, sulfur and silicon 2009;184:2645–54
   Google Scholar
• (a) Ghorab MM, Shaaban MA, Refaat HM, et al. Anticancer and radiosensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety. Eur J Med Chem 2012;53:403–7. (b) Lu X, Liu X, Wan B, et al. Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2. Eur J Med Chem 2012;49:164–71
   Google Scholar
• (a) Fallah-Tafti A, Tiwari R, Shirazi AN, Akbarzadeh T, et al. 4-Aryl-4H-chromene-3-carbonitrile derivatives: evaluation of Src kinase inhibitory and anticancer activities. Med Chem 2011;7:466–72. (b) Ghorab MM, Al-Said MS, Nissan YM. Dapson in heterocyclic chemistry, Part V: synthesis, molecular docking and anticancer activity of some novel sulfonylbiscompounds carrying biologically active dihydropyridine, dihydroisoquinoline, 1,3-dithiolan, 1,3-dithian, acrylamide, pyrazole, pyrazolopyrimidine and benzochromenemoieties. Chem Pharm Bull 2012;60:1019–28
   Google Scholar
• (a) Supuran CT. Inhibition of carbonic anhydrase IX as a novel anticancer mechanism. World J Clin Oncol 2012;3:98–103. (b) Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81. (c) Said HM, Supuran CT, Hageman C, et al. Modulation of carbonic anhydrase 9 (CA9) in human brain cancer. Curr Pharm Des 2010;16:3288–99. (d) Supuran CT. Carbonic anhydrases as drug targets. Curr Pharm Des 2008;14:601–2
   Google Scholar
• Skehan P, Storegng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Nat Cancer Inst 1990;82:1107–12
   PubMed Web of Science ®Google Scholar
• Mckibben BP, Cartwright CH, Castelhano L. Practical synthesis of tetrasubstituted thiophenes for use in compound libraries. Tetrahedron Lett 1999;40:5471–4
   Web of Science ®Google Scholar
• Scrowston RM. Recent advances in the chemistry of benzo[b]thiophenes. Adv Heterocyclic Chem 1981;29:171–249
   Google Scholar
• Tormos JV, Khodorkovsky YU, Neilands OY, Belyakov SV. A novel cyclocondensation of xanthates containing active methylene groups with isothiocyanates. Spectral data and X-ray structures of the products. Tetrahedron 1992;48:6863–74
   Web of Science ®Google Scholar
• Zhou JF, Gong GX, Zhu FX, Zhi SJ. Microwave promoted one-pot synthesis of 3-(2′-amino-3′-cyano-4′-arylpyrid-6′-yl) coumarins.. Chin Chem Lett 2009;20:37–9
   Web of Science ®Google Scholar
• Volmajer J, Toplak R, Leban I, Marechal AM. Synthesis of new iminocoumarins and their transformations into N-chloro and hydrazono compounds. Tetrahedron 2005;61:7012–21
   Web of Science ®Google Scholar
• Tars K, Vullo D, Kazaks A, et al. Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases. J Med Chem 2013;56:293–300
   PubMed Web of Science ®Google Scholar